Highline Wealth Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05K Hold
95
﹤0.01% 910
2026
Q1
$4.58K Sell
95
-64
-40% -$2.98K ﹤0.01% 757
2025
Q4
$7.71K Buy
159
+59
+59% +$2.92K ﹤0.01% 451
2025
Q3
$4.72K Sell
100
-200
-67% -$9.65K ﹤0.01% 588
2025
Q2
$14.5K Sell
300
-50
-14% -$2.56K ﹤0.01% 276
2025
Q1
$19.4K Buy
350
+253
+261% +$13.7K 0.01% 210
2024
Q4
$4.68K Buy
97
+1
+1% +$51 ﹤0.01% 350
2024
Q3
$5.53K Buy
96
+35
+57% +$1.89K ﹤0.01% 325
2024
Q2
$2.96K Buy
+61
New +$2.94K ﹤0.01% 340

Other funds holding SNY

Highline Wealth Partners's SNY Position: Q2 2026 in Review

Highline Wealth Partners held its Sanofi (SNY) position steady in Q2 2026 at 95 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Highline Wealth Partners first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.4K in Q1 2025. 109 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Highline Wealth Partners held 95 shares of Sanofi worth $4.05K as of Q2 2026.
  • Highline Wealth Partners left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #910 holding.
  • Highline Wealth Partners first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
  • Highline Wealth Partners's Sanofi position peaked at $19.4K in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.